FIRAZYR

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug FIRAZYR contains one active pharmaceutical ingredient (API):

1	Icatibant UNII 325O8467XK - ICATIBANT ACETATE
	Icatibant is a selective competitive antagonist at the bradykinin type 2 (B2) receptor. It is a synthetic decapeptide with a structure similar to bradykinin, but with 5 non-proteinogenic amino acids. In HAE increased bradykinin concentrations are the key mediator in the development of the clinical symptoms.
	Read more about Icatibant

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FIRAZYR Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B06AC02	Icatibant	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	501121040039017
CA	Health Products and Food Branch	02425696
EE	Ravimiamet	1381632, 1523607
ES	Centro de información online de medicamentos de la AEMPS	08461001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	146529
FR	Base de données publique des médicaments	61680479
GB	Medicines & Healthcare Products Regulatory Agency	150324
HK	Department of Health Drug Office	66935
IE	Health Products Regulatory Authority	88148
IL	מִשְׂרַד הַבְּרִיאוּת	6312
JP	医薬品医療機器総合機構	4490406G1029
LT	Valstybinė vaistų kontrolės tarnyba	1033654, 1063755
NL	Z-Index G-Standaard, PRK	128635
NZ	Medicines and Medical Devices Safety Authority	17717
PL	Rejestru Produktów Leczniczych	100218256
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68202001
US	FDA, National Drug Code	54092-702